Literature DB >> 12682214

Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.

Christophe Rousselle1, Philippe Clair, Maria Smirnova, Yuri Kolesnikov, Gavril W Pasternak, Stephanie Gac-Breton, Anthony R Rees, Jean-Michel Scherrmann, Jamal Temsamani.   

Abstract

The blood-brain barrier restricts the passage of substances into the brain. Neuropeptides, such as enkephalins, cannot be delivered into the brain when given systemically because of this barrier. Therefore, there is a need to develop efficient transport systems to deliver these drugs to the brain. Recently, we have demonstrated that conjugation of doxorubicin or penicillin to peptide vectors significantly enhances their brain uptake. In this study, we have conjugated the enkephalin analog dalargin with two different peptide vectors, SynB1 and SynB3, to improve its brain delivery and its pharmacological effect. We show by in situ brain perfusion that vectorization markedly enhances the brain uptake of dalargin. We also show using the hot-plate model that this enhancement in brain uptake results in a significant improvement in the observed antinociceptive effect of dalargin. These results support the usefulness of peptide-mediated strategies for improving the availability and efficacy of central nervous system drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682214     DOI: 10.1124/jpet.102.048520

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.

Authors:  Liuyin Zhang; Charles R Robertson; Brad R Green; Timothy H Pruess; H Steve White; Grzegorz Bulaj
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

Review 2.  Experimental methods and transport models for drug delivery across the blood-brain barrier.

Authors:  Bingmei M Fu
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

Review 3.  Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.

Authors:  Surya K Mallapragada; Timothy M Brenza; JoEllyn M McMillan; Balaji Narasimhan; Donald S Sakaguchi; Anup D Sharma; Svitlana Zbarska; Howard E Gendelman
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

4.  Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders.

Authors:  Govinda Shivaji Jadhav; Tejas Girish Agnihotri; Bichismita Sahu; Aakanchha Jain
Journal:  Drug Deliv Transl Res       Date:  2022-05-15       Impact factor: 4.617

Review 5.  Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

Authors:  Luc Bertrand; Madhavan Nair; Michal Toborek
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 6.  CNS delivery via adsorptive transcytosis.

Authors:  Françoise Hervé; Nicolae Ghinea; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2008-08-26       Impact factor: 4.009

7.  Targeting the APP-Mint2 Protein-Protein Interaction with a Peptide-Based Inhibitor Reduces Amyloid-β Formation.

Authors:  Christian R O Bartling; Thomas M T Jensen; Shawna M Henry; Anna L Colliander; Vita Sereikaite; Marcella Wenzler; Palash Jain; Hans M Maric; Kasper Harpsøe; Søren W Pedersen; Louise S Clemmensen; Linda M Haugaard-Kedström; David E Gloriam; Angela Ho; Kristian Strømgaard
Journal:  J Am Chem Soc       Date:  2021-01-05       Impact factor: 15.419

8.  Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.

Authors:  Li-Li Zou; Jie-Lan Ma; Tao Wang; Tang-Bin Yang; Chang-Bai Liu
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

9.  In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.

Authors:  Xin-hua Tian; Feng Wei; Tian-xiao Wang; Peng Wang; Xiao-ning Lin; Jun Wang; Dong Wang; Lei Ren
Journal:  Int J Nanomedicine       Date:  2012-02-23

Review 10.  Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.

Authors:  Gabriel A Silva
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.